scispace - formally typeset
E

Eva Bentmann

Researcher at Ludwig Maximilian University of Munich

Publications -  6
Citations -  1720

Eva Bentmann is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Neurodegeneration & RNA-Binding Protein FUS. The author has an hindex of 6, co-authored 6 publications receiving 1496 citations. Previous affiliations of Eva Bentmann include German Center for Neurodegenerative Diseases.

Papers
More filters
Journal ArticleDOI

FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.

TL;DR: Data imply different pathological processes underlying inclusion formation and cell death between both conditions; the pathogenesis in amyotrophic lateral sclerosis with FUS mutations appears to be more restricted to dysfunction of fused in sarcoma, while a more global and complex dysregulation of all FET proteins is involved in the subtypes of frontotemporal lobar degeneration with fused in Sarcoma pathology.
Journal ArticleDOI

Requirements for stress granule recruitment of fused in Sarcoma (FUS) and TAR DNA binding protein of 43 kDa (TDP-43)

TL;DR: The requirements for SG recruitment of FUS and TDP-43 were determined and it was found that cytoplasmic mislocalization is a common prerequisite for SG recruited of F US and T DP-43.
Journal ArticleDOI

Stress granules in neurodegeneration--lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma.

TL;DR: It is proposed that pathological inclusions containing RNA‐binding proteins, such as TDP‐43 and FUS, might arise from SGs and discussed how SGs might contribute to neurodegeneration via toxic gain or loss‐of‐function mechanisms.